Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related NERV
The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Snags BARDA Funding
The Daily Biotech Pulse: Novartis Breast Cancer Trial Meets Endpoint, Medpace's Offering, Dexcom Buys TypeZero
Related ESRT
4 Reasons For BTIG's Bearish Turn On Empire State Realty Trust
Goldman On REITs: Buy SL Green, Sell Paramount Group
Empire State Realty Trust, Inc.'s (ESRT) CEO Tony Malkin on Q4 2018 Results - Earnings Call Transcript (Seeking Alpha)

Analysts at JMP Securities initiated coverage on Minerva Neurosciences (NASDAQ: NERV) with a Market Perform rating. The target price for Minerva Neurosciences is set to $16. Minerva Neurosciences' shares closed at $6.78 on Friday.

Wells Fargo initiated coverage on shares of Empire State Realty Trust (NYSE: ESRT) with a Market Perform rating. Empire State Realty Trust's shares closed at $16.40 on Friday.

Analysts at Keefe Bruyette & Woods initiated coverage on shares of Greenlight Reinsurance (NASDAQ: GLRE) with a Outperform rating. The target price for Greenlight Reinsurance is set to $40. Greenlight Reinsurance's shares closed at $33.57 on Friday.

Argus Research initiated coverage on shares of Dollar General (NYSE: DG) with a Hold rating. Dollar General's shares closed at $55.61 on Friday.

Latest Ratings for NERV

DateFirmActionFromTo
Mar 2017JefferiesInitiates Coverage OnBuy
May 2016JefferiesMaintainsBuy
May 2016JefferiesAssumesBuy

View More Analyst Ratings for NERV
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (DG + ESRT)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
SSTIImperial CapitalDowngrades49.0
OSPNImperial CapitalDowngrades20.0
ENBLStifel NicolausUpgrades17.0
FAROGabelli & Co.Upgrades0.0
BDCLongbow ResearchDowngrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

AcelRX Selling Off Sharply On FDA Reexamination

UPDATE: Bank Of America Reiterates On WellCare Health Plans On Disappointing Q2, Attractive Risk/Reward